USPTO serial 79064321
CAN
Reviewed by CopyMark Law Group
Reg. 3752438Status 404
- Filing date
- Status date
- Registration date
- Feb 23, 2010
- Examiner
- WHITTAKER BROWN, TRACY
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Centrum für Angewandte Nanotechnologie (CAN) GmbH
Hamburg, DE
Other trademarks owned by Centrum für Angewandte Nanotechnologie (CAN) GmbH
Centrum für Angewandte; Nanotechnologie (CAN) GmbH
DE
Other trademarks owned by Centrum für Angewandte; Nanotechnologie (CAN) GmbH
Centrum für Angewandte Nanotechnologie (CAN) GmbH
Hamburg, DE
Other trademarks owned by Centrum für Angewandte Nanotechnologie (CAN) GmbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles P. Bacall
Charles P. Bacall Verrill Dana, LLPOne Portland SquareP.O. Box 586Portland, ME 04112-0586Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; [ unprocessed artificial resins, unprocessed plastics: ] all the aforesaid goods being goods made from nanoparticles and nanostructures | SECTION 70 - CANCELLED | — |
| 005 | [ Pharmaceutical preparations for the diagnosis and therapy of skin disorders, eye disorders, cancer, diabetes, CNS disorders (CNS = Central Nervous System), stomach and intestine disorders, orthopaedic disorders, liver disorders, kidney disorders, spleen disorders, muscular skeletal disorders, autoimmune disorders, inflamatory disorders, pulmonary disorders, cardiovascular disorders; pharmaceutical preparations for discovering forgery in the nature of making or imitating legitimate preparations with the intent of defrauding consumers in the fields of medicine, pharmacology, laboratory preparations, toxicology preparations; Contrast agents for use with medical imaging equipment, namely, angiographic contrast applications, magnetic resonance tomography applications (MRT), x-ray applications, positron emission tomography (PET), optical coherence tomography (OCT); Sanitary preparations for medical purposes; sanitary preparations for sterilizing surfaces; dietetic preparations, namely, food adapted for medical purposes; medical plasters, surgical plasters, surgery thread; materials for dressing in the nature of gauze, medical patches, namely, transdermal patches for use in treating skin diseases and skin disorders; Disinfectants for medical purposes, sanitary purposes, laboratory purposes, cleaning purposes; All the afore-said goods being made from nanoparticles and nanostructures ] | SECTION 71 - CANCELLED | — |
| 042 | [ Services in the field of science, technology, research and development, namely, scientific research, product research and development in the fields of nanotechnology, medicine, pharmacology, scientific laboratory, toxicology; Industrial analysis and research in the fields of nanotechnology, medicine, pharmacology, scientific laboratory, toxicology; quality control for others in the nature of quality monitoring of nanomaterials, namely, nanoparticles, contrast agents and angiographic contrast applications; technical tests and checks, namely, technical research in the fields of nanotechnology, medicine, pharmacology, scientific laboratory, toxicology; certification services, namely, evaluation of the goods and/or services of others for the purpose of certification in the fields of nanotechnology, medicine, pharmacology, scientific laboratory, toxicology; quality inspection of nanomaterials and certification of facilities, namely, testing, analysis and evaluation of the goods and services of others for the purpose of certification structures in the field of nanotechnology ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Centrum für Angewandte Nanotechnologie (CAN) GmbH
- Other trademarks owned by Centrum für Angewandte; Nanotechnologie (CAN) GmbH
- Other trademarks owned by Centrum für Angewandte Nanotechnologie (CAN) GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 24, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 16, 2017 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 3, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 2, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 6, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 6, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED | — |
| Apr 6, 2016 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Apr 6, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 22, 2016 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 6, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 14, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 14, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 23, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 23, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 8, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2009 | FAXX | FAX RECEIVED | — |
| Nov 23, 2009 | FAXX | FAX RECEIVED | — |
| Nov 18, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 2, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 2, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 2, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 2, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 2, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 15, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 15, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2009 | FAXX | FAX RECEIVED | — |
| Apr 7, 2009 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 7, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 17, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 17, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 11, 2009 | PAPER RECEIVED | — | |
| Mar 6, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 6, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 6, 2009 | FAXX | FAX RECEIVED | — |
| Feb 19, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 19, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 19, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2009 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 17, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 15, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 14, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 13, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |